# CVE-2024-2259: Reflected XXS Vulnerability in InstaRISPACS Software

> Remote attackers can execute arbitrary scripts in user browsers via the loginTo parameter in InstaRISPACS, potentially stealing sessions or data.

- **Severity:** Medium 6.4 (`CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:L/VI:L/VA:N/SC:H/SI:H/SA:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Not needed
- **Attackable:** Over the internet
- **Victim action needed:** A user has to click or open something
- **Fix available:** No
- **Published:** 13 Aug 2024
- **Updated:** 13 Aug 2024
- **Also known as:** GHSA-25fr-pq5j-rg59

## What is CVE-2024-2259?

CVE-2024-2259 is a medium-severity cross-site scripting vulnerability in Meddiff Technologies InstaRISPACS, published on 13 Aug 2024. An attacker can exploit it over the internet without logging in, and only if a user opens a file or follows a link.

### Official description

This vulnerability exists in InstaRISPACS software due to insufficient validation of user supplied input for the loginTo parameter in user login module of the web interface of the application. A remote attacker could exploit this vulnerability by sending a specially crafted input to the vulnerable parameter to perform reflected Cross Site Scripting (XSS) attacks on the targeted system.

Weakness: CWE-79 (Improper Neutralization of Input During Web Page Generation)

## Which versions are affected by CVE-2024-2259?


## How do I fix CVE-2024-2259?

No fix has been published for CVE-2024-2259 yet. Limit exposure of the affected software until one is available.

## Is CVE-2024-2259 being exploited?

There is no known exploitation of CVE-2024-2259 in the wild and no public exploit code.

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2024-2259 and fix it if it is affected.

What it is: CVE-2024-2259 is a medium-severity cross-site scripting vulnerability in Meddiff Technologies InstaRISPACS, published on 13 Aug 2024. An attacker can exploit it over the internet without logging in, and only if a user opens a file or follows a link.
Exploitation: There is no known exploitation of CVE-2024-2259 in the wild and no public exploit code.

Affected product: Meddiff Technologies InstaRISPACS. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2024-2259/ (Markdown: https://insights.sbomify.com/CVE-2024-2259/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2024-2259
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2024-2259
- OSV: https://osv.dev/vulnerability/CVE-2024-2259

---
From sbomify Insights: https://insights.sbomify.com/CVE-2024-2259/
Summaries are generated and may contain mistakes; the official description above is the record.